TGFβ Controls Ovarian Cancer Cell Proliferation

Elisenda Alsina-Sanchís1,2, Agnès Figueras3,4, Alvaro Lahiguera5,6

  • 1Program Against Cancer Therapeutic Resistance (ProCURE), Institut Català d'Oncologia, Hospital Duran i Reynals, L'Hospitalet de Llobregat, 08908 Barcelona, Spain. elisenda.as@gmail.com.

Insights

Transforming Growth Factor beta (TGFβ) signaling drives ovarian cancer cell proliferation. Inhibiting this pathway offers a promising therapeutic strategy for improving survival rates in ovarian cancer patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cellular Signaling

Background:

  • Ovarian cancer survival rates have seen minimal improvement despite advances in surgery and treatment.
  • Tumor heterogeneity and diverse origins necessitate research into underlying signaling pathways.
  • The Transforming Growth Factor beta (TGFβ) family plays a crucial role in cellular processes and is implicated in various cancers.

Purpose of the Study:

  • To investigate the role of TGFβ signaling in ovarian cancer progression.
  • To elucidate the specific mechanisms by which the TGFβ pathway influences ovarian cancer cell proliferation.

Main Methods:

  • Review of existing literature on TGFβ signaling in cancer.
  • Analysis of molecular mechanisms underlying TGFβ pathway involvement in ovarian cancer.

Main Results:

  • Disruption of TGFβ signaling is a key factor in ovarian cancer development.
  • The TGFβ pathway exerts control over ovarian cancer cell proliferation through various mechanisms.

Conclusions:

  • Understanding TGFβ signaling mechanisms is critical for ovarian cancer treatment.
  • Targeting TGFβ signaling with inhibitors presents a potential therapeutic avenue for ovarian cancer, with early-phase development underway.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.7K
Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...
7.2K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.8K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K